The influence of community-acquired pneumonia to the clinical course in COPD cases admitted to intensive care unit with acute respiratory failure;Yoǧun bakim ünitesine akut solunum yetmezliǧi ile kabul edilen KOAH olgularinda pnömoni varliǧinin klinik seyre etkisi

Tuberkuloz ve Toraks

Volumn 58, Issue 4, 2010, Pages 408-417

  Güngör, Gökay ^a   Yazicioǧlu Moçin, Özlem ^a   Acartürk, Eylem ^a   Başbuǧ, Yelda ^a   Saltürk, Cüneyt ^a   Yalçinsoy, Murat ^a   Karakurt, Zuhal ^a  

^a Sureyyapasa Gogus Hastaliklari ve Gogus Cerrahisi Egitim ve Arastirma Hastanesi   (Turkey)

Author keywords

Chronic obstructive pulmonary disease; Community acquired pneumonia; Intensive care unit

Indexed keywords

C REACTIVE PROTEIN;

ACUTE RESPIRATORY FAILURE; AGED; APACHE; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GAS; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; DISEASE COURSE; FEMALE; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INVASIVE PROCEDURE; PROSPECTIVE STUDY; RISK FACTOR; SEPTIC SHOCK; VENTILATOR ASSOCIATED PNEUMONIA;

ACUTE DISEASE; AGED; C-REACTIVE PROTEIN; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; INTENSIVE CARE; LEUKOCYTE COUNT; MALE; PNEUMONIA; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; SEVERITY OF ILLNESS INDEX;

EID: 78651404456     PISSN: 04941373     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Patil S, Krishnan J, Lechtzin N, et al. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med. /2003; 163: 1180-6.
2. Groenewegen KH, Schols AMWJ, Wouters E. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003; 124: 459-67.
3. Standarts for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society Statement. Am J Respir Crit Care Med 1995; 152: 77-120.
4. Khilnani GC, Banga A, Sharma SK. Predictors of mortality of patients with acute respiratory failure secondary to chronic obstructive pulmonary disease admitted to an intensive care unit: a one year study. BMC Pulm Med 2004; 4: 12.
5. Özlü T, Bülbül Y, Özsu S. Ulusal verilerle toplumda gelişen pnömoniler. Tuberk Toraks 2007; 55: 191-212.
6. De Celis R, Torres A, Zalacain R, et al. Metodos de diagnistico y tratimiento de la neumonia adquirida en la comunidad en Espana: Estudio NACE (Diagnostic methods and treatment of community acquired pneumonia in Spain: NACE study). Med Clin (Barc) 2002; 119: 321-36.
7. Almirall J, Mesalles E, Klamgurg J, et al. Prognostic factors of pneumonia requiring admission to the intensive care unit. Chest 1995; 107: 511-6.
8. Vallés J, Pobo A, García-Esquirol O, et al. Excess ICU mortality attributable to ventilator-associated pneumonia: the role of early vs late onset Intensive Care Med 2007; 33: 1363-8.
9. Rello J, Rodriguez A, Torres A, et al. Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia. Eur Respir J 2006; 27: 1210-6.
10. Torres A, Dorca J, Zalacain J, et al. Community acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study . Am J Respir Crit Care Med 1996; 154: 1456-61.
11. Ruiz de Ona JM, Gomez Fernandez M, Celdran J,Puente-Maestu L. Neumonia en el paciente con enfermedad pulmonar obstructiva cronica. Niveles de gravedad y clases de riesgo[Pneumonia in the patient with chronic obstructive pulmonary disease. Levels of severity and risk classification]. Arch Bronconeumol 2003; 39: 101-5.
12. Molinos L, Clemente MG, Miranda B. Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease. Journal of Infection 2009; 58: 417-24.
13. Global Initiative for Chronic Lung Obstructive Lung Disease (GOLD). Global Strategy for the diagnosis, management and prevention of COPD. www.goldcopd.com (updated 2008).
14. Le Gall JR, Brun Buisson C, Trunett P, et al. Influence of age , previous health status and severity of acute illness on outcome from intensive care. Crit Care Med 1982; 10: 575-7.
15. ACCP/SCCM Consensus Conference Committee. Crit Care Med 1992; 20: 864-74.
16. British Thoracic Society Standarts of Care Committee. BTS Guideline Non-invasive ventilation in acute respiratory failure. Thorax 2002; 57: 192-211.
17. Brochard L, Mancebo J, Wysocki M, et al. Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med 1995; 333: 817-22.
18. Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med 2002; 166: 1338-44.
19. Boles JM, Bion J, Connors A, et al. Weaning from mechanical ventilation. Eur Respir J 2007; 29: 1033-56.
20. Türk Toraks Derneǧi. Erişkinlerde hastanede gelişen pnömoni tani ve tedavi uzlaşi raporu. Toraks 2009; 10(Ek 6): 1-24
21. Rello J, Pavia JA, Baraibar J, et al. International conference for the development of consensus on the diagnosis and treatment of the ventilator- associated pneumonia. Chest 2001; 120: 955-70.
22. Farr BM, Barlett CL, Wadsworth J, et al. Risk factors for community-acquired pneumonia diagnosed upon hospital admission. British Thoracic Society Pneumonia Study Group. Respir Med 2000; 94: 954-63.
23. Ruiz M, Ewig S, Marcos MA, et al. Etiology of community acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med 1999; 160: 397-405.
24. Lim WS, Van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58: 377-82.
25. Zvezdin B, Milutinov S, Kojicic M, et al. A Post mortem analysis of major causes of early death in patients hospitalized with COPD exacerbation. Chest 2009; 136: 329-30.
26. Lieberman D, Lieberman D, Gelfer Y, et al. Pneumonic vs Nonpneumonic acute exacerbations of COPD. Chest 2002; 122: 1264-70.
27. Gürsel G. Determinants of the length of mechanical ventilation in patients with COPD in the intensive care unit: Respiration 2005; 72: 61-7.
28. Wysocki M, Tric L, Wolff MA et al, Noninvasive pressure support ventilation in patients with acute respiratory failure: a randomized comparison with conventional therapy. Chest 1995; 107: 761-8.
29. Ambrosino N, Foglio K, Rubini F, et al. Non-invasive mechanical ventilation in acute respiratory failure due to chronic obstructive pulmonary disease: correlates for success. Thorax 1995; 50: 755-7.
30. Confalonieri M, Potena A, Carbone G, et al. Acute respiratory failure in patients with severe community-acquired pneumonia. A prospective randomized evaluation of noninvasive ventilation. Am J Respir Crit Care Med 1999; 160: 1585-91.
31. Liesching T, Kwok H, Hill NS. Acute applications of noninvasive positive pressure ventilation. Chest 2003; 124: 699-713.
32. America Thoracic Society . Hospital-acquired pneumonia in adults. Diagnosis, assessment of severity initial antimicrobial theraphy and preventive strategies. Am J Respir Crit Care Med 1996; 153: 1711-25.
33. Trouillet JL, Chastre J, Vuagnat A, et al. Ventilator associated pneumonia caused by potentially drug resistant bacteria. Am J Respir Crit Care Med 1998; 157: 531-9.
34. Nseir S, Di Pompeo C, Soubrier S, et al. Impact of ventilatör associated pneumonia on outcome in patients with COPD. Chest 2005; 128: 1650-6.
35. Aybar Türkoǧlu M, Topeli İskit A. Ventilator-associated pneumonia caused by high risk microorganisms: a matched case-control study. Tuberk Toraks 2008; 56: 139-49.
36. Sibila O, Luna CM, Agusti C, et al. Effect of corticoesteroids (GC) in an animal model of ventilator associated pneumonia (VAP) . Am J Respir Crit Care Med 2006; 3: A21.
37. Singh S, Amin AV, Loke YK, et al. Long term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta analysis. Arch Intern Med 2009; 169: 219-29.
38. Confalonieri M, Urbino R, Potena A, et al. Hydrocortisone infusion for severe community acquired pneumonia: a preliminary randomized study. Am J Respir Care Med 2005; 171: 242-8.
39. Garcia-Vidal C, Calbo E, Pascual V, et al. Effects of systemic steroids in patients with severe community-acquired pneumonia. Eur Respir J 2007; 30: 951-6.
40. Ucgun I, Metintas M, Moral H, et al. Predictors of hospital outcome and intubation in COPD patients admitted to the respiratory ICU for acute hypercapnic respiratory failure. Respir Med 2006; 100: 66-74.
41. Menéndez R, Martínez R, Reyes S, et al. Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax 2009; 64: 587-91.
42. Lobo SM, Lobo FR, Bota DP, et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003; 123: 2043-9.
43. Sin D, Man SFP. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases?: the potential role of systemic inflammation in chronic obstructive pulmonary disease Circulation 2003; 107: 1514-9.